
Contineum Therapeutics, Inc.
CTNMHealthcare|Biotechnology|US
$9.52
+0.71 (+8.06%)
DCF Value
$2.40
Tangible Book / Share
$6.39
Cash / Share
$6.37
Next Earnings Report
Mar 4, 2027
EPS est. -$0.49 · Revenue est. $7.5M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Mar 5, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
May 2028
Est. completion
P2Idiopathic Pulmonary Fibrosis
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
NCT07284459n=324
Recent Press Releases
Contineum Therapeutics Reports Third-Quarter 2026 Financial Results
Nov 3, 2026 · Business Wire
Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder
Sep 14, 2026 · Business Wire
Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference
Aug 25, 2026 · Business Wire
SEC Filings (65)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 3, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 3, 2026 | 8-K | Material event | DocumentIndex |
| Oct 28, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 28, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 22, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 30, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 30, 2026 | 8-K | Material event | DocumentIndex |
| Jul 27, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 13, 2026 | 8-K | Material event | DocumentIndex |
| Jun 26, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 5, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 30, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 30, 2026 | 8-K | Material event | DocumentIndex |
| Apr 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 5, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 5, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 5, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 29, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 26, 2026 | 8-K | Material event | DocumentIndex |
| Dec 15, 2025 | 8-K | Material event | DocumentIndex |
| Dec 12, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Dec 11, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Dec 11, 2025 | 8-K | Material event | DocumentIndex |
| Nov 20, 2025 | 8-K | Material event | DocumentIndex |
| Nov 4, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 30, 2025 | 10-Q | Quarterly report | DocumentIndex |